UC Irvine Health laying off 175 employees

UC Irvine Health will let go 175 employees, along with another 79 vacant positions being eliminated.

The layoffs were announced Oct. 3 in an email sent by UC Irvine Health CEO Howard Federoff, according to the Orange County Register.

“We have reduced expenses, improved efficiencies, and increased revenue by growing our clinical servicesbut it has not been enough to avoid reductions in staff,” Federoff wrote.

“Without immediate action, our expenses will exceed our operating revenue this fiscal year,” he said. The layoffs “will secure long-term stability for UC Irvine Health, our patients and the communities we serve.”

Physicians and teaching positions were not being cut. The California Nurses Association said six nursing positions were being eliminated, while 68 workers in technical or service jobs would be let go, according to the American Federation American Federation of State, County and Municipal Employees (AFSCME).

UC Irvine's medical center “is a public hospital that has a staffing and priorities problemnot a profit problem,” said AFSCME spokesman Todd Stenhouse.

UC Irvine spokesman John Murray told the Los Angeles City News Service the hospital was been pressured financially by changes in reimbursements from Medicare and private insurers.

“Reimbursements are somewhat flat, and there’s an increasing demand on academic centers across the country,” Murray said. “Academic medical centers like UCLA, NYU, Stanford, all these systems have to support an academic enterprise, a school of medicine, as well as research, so our costs are higher and we have to become more efficient.”

The email to staff also blamed the Affordable Care Act, saying it’s “strained our capacity,” and Murray mentioned the hospital has been dealing with more complex patients and referrals from community hospitals.

The cuts in staff will hopefully save the medical system $40 million in its current fiscal year and $100 million in fiscal year 2018, according to Murray.  

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.